Scientific Insights Center

AliveDx is proud to announce that we have successfully completed the 2025/26 NHS Evergreen Sustainable Supplier Assessment, achieving Level 2 status in the UK. This annual assessment is a key benchmark for suppliers to the NHS in the UK, measuring

AliveDx Suisse S.A. is pleased to announce the signing of a strategic distribution agreement with Medipac Technologies Ltd, a leading healthcare-solutions provider in Bangladesh. Under this partnership, Medipac Technologies Ltd will distribute AliveDx’s innovative MosaiQ® and LumiQ® diagnostic platforms across Bangladesh, effective immediately.  This collaboration strengthens AliveDx’s commitment to expanding

Following our recent announcement that AliveDx had been shortlisted, we’re proud to confirm that we’ve now been officially recognised as one of the UK’s Best Workplaces in Biopharma with the list now published in The Guardian. This recognition places AliveDx

We’re proud to announce that AliveDx has been officially recognised as one of the UK’s Best Workplaces in BioPharma™ 2025 by Great Place to Work® UK. This is a prestigious honour that places us among the top 30 biopharma companies

AliveDx Suisse S.A. (AliveDx) and Transmedic Indonesia, Thailand and Singapore have signed a second distribution agreement, enabling Transmedic to distribute the LumiQ® solution across these markets. The distribution agreement takes effect immediately. This partnership underscores AliveDx’s dedication to expanding its

AliveDx Suisse S.A. (AliveDx) and Vital Care Production Distribution et Logistique SPA (Vital Care), have signed a second distribution agreement, which will enable Vital Care to distribute the LumiQ® solution in Algeria. The distribution agreement takes effect immediately. This partnership